Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

3.110 -0.040 (-1.27%)
Official Closing Price Updated: 6:30 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,356
Open 3.170
Bid (Size) 3.000 (300)
Ask (Size) 3.270 (200)
Prev. Close 3.150
Today's Range 3.110 - 3.170
52wk Range 3.100 - 6.990
Shares Outstanding 8,288,414
Dividend Yield 9.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cryo-Cell Receives NYSE American Continued Listing Notice
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
From Cryo-Cell International, Inc.
Via Business Wire

Performance

YTD
-9.3%
-9.3%
1 Month
-7.7%
-7.7%
3 Month
-25.4%
-25.4%
6 Month
-30.6%
-30.6%
1 Year
-52.2%
-52.2%

More News

Read More
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell International, Inc. Provides Dividend Update
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Looking Into Cryo-Cell International's Return On Capital Employed ↗
Via Benzinga
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024 ↗
Via InvestorPlace
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Cryo-Cell International, Inc. - Common Stock publicly traded?
Yes, Cryo-Cell International, Inc. - Common Stock is publicly traded.
What exchange does Cryo-Cell International, Inc. - Common Stock trade on?
Cryo-Cell International, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Cryo-Cell International, Inc. - Common Stock?
The ticker symbol for Cryo-Cell International, Inc. - Common Stock is CCEL on the New York Stock Exchange
What is the current price of Cryo-Cell International, Inc. - Common Stock?
The current price of Cryo-Cell International, Inc. - Common Stock is 3.110
When was Cryo-Cell International, Inc. - Common Stock last traded?
The last trade of Cryo-Cell International, Inc. - Common Stock was at 03/12/26 06:30 PM ET
What is the market capitalization of Cryo-Cell International, Inc. - Common Stock?
The market capitalization of Cryo-Cell International, Inc. - Common Stock is 25.78M
How many shares of Cryo-Cell International, Inc. - Common Stock are outstanding?
Cryo-Cell International, Inc. - Common Stock has 26M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.